2
Jan
2024
Rebooting AI in Drug Discovery on the Slope of Enlightenment
The past few years have seen a wave of AI investment in drug discovery in both large pharma companies and in venture-backed biotech startups. Expectations are running high. Management teams are betting that even marginal improvements on the ~90% failure rate of clinical trials will be worth the investment. While there have been hints of improved R&D metrics in... Read More